SFERA Archivio dei prodotti della Ricerca dell'Università di Ferrara

CORALLINI, Federica
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 4.953
AS - Asia 2.103
EU - Europa 947
SA - Sud America 276
AF - Africa 52
Continente sconosciuto - Info sul continente non disponibili 38
OC - Oceania 9
Totale 8.378
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 4.866
SG - Singapore 794
CN - Cina 602
VN - Vietnam 226
BR - Brasile 217
UA - Ucraina 190
DE - Germania 161
IT - Italia 150
GB - Regno Unito 148
HK - Hong Kong 139
TR - Turchia 127
FI - Finlandia 62
FR - Francia 60
CA - Canada 55
SE - Svezia 49
BD - Bangladesh 44
IN - India 37
RU - Federazione Russa 37
ZA - Sudafrica 27
JP - Giappone 24
PL - Polonia 24
AR - Argentina 22
PK - Pakistan 20
IQ - Iraq 19
MX - Messico 18
NL - Olanda 13
CO - Colombia 11
CZ - Repubblica Ceca 11
EC - Ecuador 11
ID - Indonesia 11
ES - Italia 10
AE - Emirati Arabi Uniti 8
AU - Australia 8
SA - Arabia Saudita 7
UZ - Uzbekistan 7
VE - Venezuela 7
EG - Egitto 6
JM - Giamaica 6
LT - Lituania 6
MA - Marocco 6
MY - Malesia 6
BE - Belgio 5
IR - Iran 5
RO - Romania 5
CL - Cile 4
IL - Israele 4
PH - Filippine 4
DZ - Algeria 3
HR - Croazia 3
KE - Kenya 3
KG - Kirghizistan 3
MD - Moldavia 3
NP - Nepal 3
HN - Honduras 2
IE - Irlanda 2
JO - Giordania 2
KR - Corea 2
LY - Libia 2
OM - Oman 2
PA - Panama 2
PE - Perù 2
RS - Serbia 2
TH - Thailandia 2
UY - Uruguay 2
AZ - Azerbaigian 1
BG - Bulgaria 1
CI - Costa d'Avorio 1
CR - Costa Rica 1
CY - Cipro 1
DK - Danimarca 1
EE - Estonia 1
ET - Etiopia 1
EU - Europa 1
GP - Guadalupe 1
GR - Grecia 1
HU - Ungheria 1
KW - Kuwait 1
LB - Libano 1
NI - Nicaragua 1
NZ - Nuova Zelanda 1
PR - Porto Rico 1
SK - Slovacchia (Repubblica Slovacca) 1
SN - Senegal 1
TG - Togo 1
TN - Tunisia 1
TW - Taiwan 1
Totale 8.341
Salva come PNG Salva come JPEG
Città #
Ashburn 507
Fairfield 505
Woodbridge 470
Singapore 452
San Jose 312
Houston 271
Seattle 223
Ann Arbor 221
Chandler 211
Jacksonville 210
Cambridge 183
Beijing 175
Santa Clara 175
Wilmington 166
Hong Kong 137
Council Bluffs 108
Los Angeles 92
New York 88
Dallas 83
Ho Chi Minh City 83
Nanjing 69
Izmir 66
Hanoi 50
Princeton 47
San Diego 37
Lauterbourg 36
Munich 36
Boardman 34
Milan 32
Buffalo 27
Shanghai 27
Shenyang 25
São Paulo 24
Nanchang 23
Tokyo 23
Ferrara 21
Orem 20
Warsaw 20
Johannesburg 17
Montreal 16
The Dalles 15
Tianjin 15
Changsha 14
London 14
Chicago 13
Da Nang 13
Falls Church 13
Jinan 13
San Mateo 13
Chennai 12
Poplar 12
San Francisco 12
Turku 12
Auburn Hills 11
Frankfurt am Main 11
Haiphong 11
Hebei 11
Mexico City 11
Mountain View 11
Zhengzhou 11
Phoenix 10
Toronto 10
Atlanta 9
Dearborn 9
Hefei 9
Manchester 9
Stockholm 9
Brooklyn 8
Columbus 8
Falkenstein 8
Helsinki 8
Philadelphia 8
Baghdad 7
Bremen 7
Brno 7
Moscow 7
Rome 7
Boston 6
Brasília 6
Guangzhou 6
Haikou 6
Ottawa 6
Redwood City 6
Rio de Janeiro 6
Vancouver 6
Amsterdam 5
Brussels 5
Bắc Ninh 5
Charlotte 5
Curitiba 5
Denver 5
Des Moines 5
Guarulhos 5
Istanbul 5
Jakarta 5
Kunming 5
Norwalk 5
Paris 5
Porto Alegre 5
Tappahannock 5
Totale 5.833
Salva come PNG Salva come JPEG
Nome #
Nutlin-3 up-regulates the expression of Notch1 in both myeloid and lymphoid leukemic cells, as part of a negative feedback antiapoptotic mechanism 269
Antiangiogenic activity of the MDM2 antagonist nutlin-3 261
Conjunctival sac fluid contains elevated levels of soluble TRAIL: implications for the anti-tumoral surveillance of the anterior surface of the eye 256
Association of tumor necrosis factor-related apoptosis-inducing ligand with total and cardiovascular mortality in older adults 251
Anti-leukemic activity of Dasatinib in both p53 wild-type and p53 mutated B malignant cells 242
Human bone marrow mesenchymal stem cells display anti-cancer activity in SCID mice bearing disseminated non-hodgkin's lymphoma xenografts 238
Elevated levels of TRAIL in systemic lupus erythematosus are associated to the presence of anti-SSA/SSB antibodies 237
Circulating levels of frizzled-related protein (FRZB) are increased in patients with early rheumatoid arthritis and decrease in response to disease-modifying antirheumatic drugs. 237
Evidence for a role of TNF-related apoptosis-inducing ligand (TRAIL) in the anemia of myelodysplastic syndromes 232
TRAIL promotes the survival, migration and proliferation of vascular smooth muscle cells 227
TRAIL counteracts the proadhesive activity of inflammatory cytokines in endothelial cells by down-modulating CCL8 and CXCL10 chemokine expression and release 221
Is there any role for tumour necrosis factor related apoptosis inducing ligand–osteoprotegerin (TRAIL–OPG) interaction in rheumatoid arthritis? 217
Mesenchymal stem cells-derived vascular smooth muscle cells release abundant levels of osteoprotegerin 216
In vivo anti-lymphoma activity of an agonistic human recombinant anti-TRAIL-R2 minibody. 215
Mesenchymal stem cells display hepato-protective activity in lymphoma bearing xenografts 199
Tumor necrosis factor-related apoptosis-inducing ligand promotes migration of human bone marrow multipotent stromal cells 193
Osteoprotegerin induces morphological and functional alterations in mouse pancreatic islets. 192
Activation of the p53 pathway down-regulates the osteoprotegerin expression and release by vascular endothelial cells 192
TRAIL inhibits osteoclastic differentiation by counteracting RANKL-dependent p27Kip1 accumulation in pre-osteoclast precursors 189
Potential role of PKC inhibitors in the treatment of hematological malignancies 187
Role of the RANKL/RANK system in the induction of interleukin-8 (IL-8) in B chronic lymphocytic leukemia (B-CLL) cells 185
TRAIL and osteoprotegerin: a role in endothelial physiopathology? 173
The tumour necrosis factor-related apoptosis inducing ligand-osteoprotegerin system in limited systemic sclerosis: a new disease marker? 173
Systemic tumor necrosis factor-related apoptosis-inducing ligand delivery shows antiatherosclerotic activity in apolipoprotein E-null diabetic mice 173
Trail down-regulates the release of osteoprotegerin (OPG) by primary stromal cells 168
Potential prognostic significance of decreased serum levels of TRAIL after acute myocardial infarction 167
An increased osteoprotegerin serum release characterizes the early onset of diabetes mellitus and may contribute to endothelial cell dysfunction 166
TRAIL, caspases and maturation of normal and leukemic myeloid precursors 161
An imbalanced OPG/TRAIL ratio is associated to severe acute myocardial infarction 161
TNFRSF11B (tumor necrosis factor receptor superfamily, member 11b) 160
Metalloproteinase 2 cleaves in vitro recombinant TRAIL: Potential implications for the decreased serum levels of TRAIL after acute myocardial infarction 147
The soluble terminal complement complex (SC5b-9) up-regulates osteoprotegerin expression and release by endothelial cells: implications in rheumatoid arthritis 146
Differential effects of chemotherapeutic drugs versus the MDM-2 antagonist nutlin-3 on cell cycle progression and induction of apoptosis in SKW6.4 lymphoblastoid B-cells 141
Ruolo di trail nella patogenesi del danno neuronale indotto dalla proteina Tat di HIV-1 129
Evidence for a proangiogenic activity of TNF-related apoptosis-inducing ligand 129
Baseline serum concentrations of TRAIL in early rheumatoid arthritis: Relationship with response to disease-modifying antirheumatic drugs 128
Human Full-Length Osteoprotegerin Induces the Proliferation of Rodent Vascular Smooth Muscle Cells both in vitro and in vivo 123
TNF-α modulates the migratory response of mesenchymal stem cells to TRAIL 115
null 102
Insulin down-regulates TRAIL expression in vascular smooth muscle cells both in vivo and in vitro 102
null 97
null 94
null 90
null 89
null 88
null 86
Osteoprotegerin increases leukocyte adhesion to endothelial cells both in vitro and in vivo 85
null 78
null 74
null 65
Selective induction of TP53I3/p53-inducible gene 3 (PIG3) in myeloid leukemic cells, but not in normal cells, by Nutlin-3 63
The potential role of Nutlins in the treatment of B-chronic lymphocytic leukemia (B-CLL) 49
Totale 8.378
Salva come PNG Salva come JPEG
Categoria #
all - tutte 35.588
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 35.588
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022450 0 0 56 11 15 26 35 25 14 29 66 173
2022/2023457 40 23 17 49 80 78 25 40 47 7 28 23
2023/2024197 16 26 3 5 11 51 9 13 1 3 3 56
2024/2025988 21 32 66 50 144 72 23 47 216 75 143 99
2025/20262.756 281 99 287 344 394 189 329 118 259 299 107 50
2026/2027300 58 159 83 0 0 0 0 0 0 0 0 0
Totale 8.378